Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Impact of January 2021 curfew measures on SARS-CoV-2 B.1.1.7 circulation in France

View ORCID ProfileLaura Di Domenico, Chiara E. Sabbatini, View ORCID ProfileGiulia Pullano, Daniel Lévy-Bruhl, View ORCID ProfileVittoria Colizza
doi: https://doi.org/10.1101/2021.02.14.21251708
Laura Di Domenico
1INSERM, Sorbonne Université, Pierre Louis Institute of Epidemiology and Public Health, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Laura Di Domenico
Chiara E. Sabbatini
1INSERM, Sorbonne Université, Pierre Louis Institute of Epidemiology and Public Health, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giulia Pullano
1INSERM, Sorbonne Université, Pierre Louis Institute of Epidemiology and Public Health, Paris, France
2Orange Labs, Sociology and Economics of Networks and Services (SENSE), Chatillon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Giulia Pullano
Daniel Lévy-Bruhl
3Santé publique France, Saint-Maurice, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vittoria Colizza
1INSERM, Sorbonne Université, Pierre Louis Institute of Epidemiology and Public Health, Paris, France
4Tokyo Tech World Research Hub Initiative, Institute of Innovative Research, Tokyo Institute of Technology, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vittoria Colizza
  • For correspondence: vittoria.colizza{at}inserm.fr
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Article usage

Article usage: February 2021 to May 2026

AbstractFullPdf
Feb 2021159334603
Mar 20211951450713
Apr 20219872894457
May 202127047580
Jun 202115812842
Jul 202113217444
Aug 202111812829
Sep 20211048928
Oct 2021928814
Nov 2021230126156
Dec 202119193378
Jan 202211290542
Feb 202210156333
Mar 20221026319
Apr 202297679
May 20221035717
Jun 20228963125
Jul 20227650111
Aug 202258105
Sep 202280810
Oct 20226785
Nov 20225456
Dec 202241913
Jan 202330105
Feb 2023242414
Mar 202333132
Apr 2023381315
May 202327811
Jun 202319308
Jul 202313168
Aug 2023302710
Sep 202331158
Oct 202316148
Nov 2023191710
Dec 202318107
Jan 20241683
Feb 2024201214
Mar 20241475
Apr 2024151829
May 2024111115
Jun 2024201116
Jul 2024271820
Aug 2024423129
Sep 2024483017
Oct 202419159
Nov 2024321213
Dec 2024191112
Jan 202524158
Feb 2025235110
Mar 2025375340
Apr 2025272839
May 2025353937
Jun 2025484634
Jul 2025493933
Aug 2025352748
Sep 2025344467
Oct 2025243727
Nov 2025644283
Dec 2025283996
Jan 2026645578
Feb 20266412670
Mar 2026689040
Apr 2026494570
May 20266866149
Back to top
PreviousNext
Posted March 10, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Impact of January 2021 curfew measures on SARS-CoV-2 B.1.1.7 circulation in France
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Impact of January 2021 curfew measures on SARS-CoV-2 B.1.1.7 circulation in France
Laura Di Domenico, Chiara E. Sabbatini, Giulia Pullano, Daniel Lévy-Bruhl, Vittoria Colizza
medRxiv 2021.02.14.21251708; doi: https://doi.org/10.1101/2021.02.14.21251708
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Impact of January 2021 curfew measures on SARS-CoV-2 B.1.1.7 circulation in France
Laura Di Domenico, Chiara E. Sabbatini, Giulia Pullano, Daniel Lévy-Bruhl, Vittoria Colizza
medRxiv 2021.02.14.21251708; doi: https://doi.org/10.1101/2021.02.14.21251708

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (576)
  • Allergy and Immunology (868)
  • Anesthesia (306)
  • Cardiovascular Medicine (4483)
  • Dentistry and Oral Medicine (449)
  • Dermatology (385)
  • Emergency Medicine (615)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1528)
  • Epidemiology (15283)
  • Forensic Medicine (31)
  • Gastroenterology (1134)
  • Genetic and Genomic Medicine (6651)
  • Geriatric Medicine (671)
  • Health Economics (1006)
  • Health Informatics (4606)
  • Health Policy (1378)
  • Health Systems and Quality Improvement (1624)
  • Hematology (545)
  • HIV/AIDS (1276)
  • Infectious Diseases (except HIV/AIDS) (15965)
  • Intensive Care and Critical Care Medicine (1111)
  • Medical Education (626)
  • Medical Ethics (147)
  • Nephrology (675)
  • Neurology (6699)
  • Nursing (346)
  • Nutrition (1006)
  • Obstetrics and Gynecology (1153)
  • Occupational and Environmental Health (961)
  • Oncology (3370)
  • Ophthalmology (989)
  • Orthopedics (370)
  • Otolaryngology (421)
  • Pain Medicine (437)
  • Palliative Medicine (131)
  • Pathology (670)
  • Pediatrics (1704)
  • Pharmacology and Therapeutics (700)
  • Primary Care Research (717)
  • Psychiatry and Clinical Psychology (5497)
  • Public and Global Health (9288)
  • Radiology and Imaging (2225)
  • Rehabilitation Medicine and Physical Therapy (1375)
  • Respiratory Medicine (1202)
  • Rheumatology (598)
  • Sexual and Reproductive Health (721)
  • Sports Medicine (536)
  • Surgery (722)
  • Toxicology (100)
  • Transplantation (290)
  • Urology (267)